Aug 05, 2019
Biocept to Release Second Quarter 2019 Financial Results and Host Investor Conference Call on August 12, 2019
Jun 03, 2019
Biocept to Present at the 9th Annual LD Micro Invitational Conference on June 4
May 28, 2019
Biocept Awarded Patent in China for its Circulating Tumor Cell Platform Expanding Intellectual Property Estate to 33 Issued Patents Globally
May 01, 2019
Biocept to Release First Quarter 2019 Financial Results and Host Investor Conference Call on May 8, 2019
Mar 28, 2019
Biocept Reports 2018 Fourth Quarter and Full Year Financial Results
Mar 26, 2019
Biocept Broadens Commercial Focus of its Target Selector Liquid Biopsy Platform to Include Urology Market Segment
Mar 21, 2019
Biocept to Release 2018 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 28, 2019
Mar 18, 2019
Biocept Awarded Patent in Japan for the Capture of Rare Cells Including CTCs from Any Biological Sample of Interest with A Microchannel Device
Mar 15, 2019
Biocept Announces Pricing of $8.2 Million Registered Direct Offering
Mar 04, 2019
Biocept's Liquid Biopsy Test for ESR1 Biomarker Detection to be Featured in Poster Presentation at the 2019 AACR Annual Meeting
Feb 27, 2019
Biocept and Providence Saint John's Health Center Collaborate to Evaluate Cerebrospinal Fluid for Use with Liquid Biopsy Testing in Metastatic Cancer
Feb 20, 2019
Biocept Issues Letter to Stockholders
Feb 20, 2019
Global Liquid Biopsy Market to 2024 Featuring Thermo Fisher Scientific, Roche Diagnostics, Bio-Rad Labs, Biocept, Biocartis, Myriad Genetics, Genomic Health, NeoGenomics Laboratories, & Qiagen
Feb 08, 2019
Biocept Announces Pricing of $7.5 Million Underwritten Public Offering
Jan 18, 2019
Biocept Announces Pricing of $2.2 Million Registered Direct Offering
Dec 18, 2018
Biocept and Prognos Enter Into Partnership to Apply Artificial Intelligence in Order to Help Pharmaceutical and Life Sciences Companies Optimize Commercialization of Biomarker-Targeted Therapies in Oncology
Nov 06, 2018
Biocept to Release Third Quarter 2018 Financial Results and Host Investor Conference Call on November 13, 2018
Nov 05, 2018
Biocept Announces New Executive Hires to its Sales and Marketing Organization
Oct 23, 2018
Biocept to Present at the Dawson James Securities Small Cap Growth Conference on October 30
Oct 18, 2018
Biocept Obtains Japanese Patent for its Target Selector Oncogene Mutation Enrichment and Detection Platform